Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells

Blood

Volumn 107, Issue 1, 2006, Pages 60-62

  Goodwin, Richard G ^b   Kell, W Jonathan ^b   Laidler, Peter ^b   Long, C Colin ^b   Whatley, Sharon D ^b   McKinley, Mark ^b   Badminton, Michael N ^b   Burnett, Alan K ^b   Williams, Geraint T ^b   Elder, George H ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERROCHELATASE; PROTOPORPHYRIN;

ADULT; ALLELE; ARTICLE; BONE MARROW CELL; CASE REPORT; CELL CLONE; DISEASE COURSE; DISEASE SEVERITY; ENZYME DEFICIENCY; ERYTHROPOIETIC PROTOPORPHYRIA; GENE DELETION; GENETIC ASSOCIATION; GENETIC DISORDER; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; INTRAHEPATIC CHOLESTASIS; LIVER INJURY; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PHOTOSENSITIVITY; PRIORITY JOURNAL; SOMATIC MUTATION; SYMPTOMATOLOGY;

EID: 30144434692     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2004-12-4939     Document Type: Article

References (20)

1. Todd DJ. Erythropoietic protoporphyria. Brit J Dermatol. 1994;131:751-766.
2. Gouya L, Puy H, Robreau AM, et al. The penetrance of autosomal dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet. 2002;30:27-30.
3. Risheg H, Chen FP, Bloomer JR. Genotype determinants of phenotype in North American patients with erythropoietic protoporphyria. Mol Genet Metab. 2003;80:196-206.
4. Whatley SD, Mason NG, Khan M, et al. Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease. J Med Genet. 2004;41:e105.
5. Bloomer JR. The liver in protoporphyria. Hepatol. 1988;8:402-407.
6. Meerman L. Erythropoietic protoporphyria: an overview with emphasis on the liver. Scand J Gastroenterol. 2000;35(suppl 232):79-85.
7. Lim HW, Cooper D, Sassa S, et al. Photosensitivity, abnormal porphyrin profile, and sideroblastic anemia. J Am Acad Dermatol. 1992;27:287-292.
8. Shirota T, Yamamoto H, Hayashi S, et al. Myelodysplastic syndrome terminating in erythropoietic protoporphyria after 15 years of aplastic anemia. Int J Hematol. 2000;72:44-47.
9. Aplin C, Whatley SD, Thompson P, et al. Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells. J Invest Dermatol. 2001;117:1647-1649.
10. Spann CT, Tok J, Nimer S, Zug K, Deleo V. Adult onset erythropoietic protoporphyria in association with myelodysplastic syndrome [abstract]. American Academy of Dermatology Annual Meeting, New Orleans, LA, February 22-27, 2002.
11. Yau SC, Bobrow M, Mathew CG, Abbs SJ. Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet. 1996;33:550-558.
12. Deacon AC, Elder GH. Front line tests for the investigation of suspected porphyria. J Clin Pathol. 2001;54:500-507.
13. Cox TM. Protoporphyria. In: The Porphyrin Handbook: Medical Aspects of Porphyrias. Vol 14. Kadish KM, Smith KM, Guilard R, eds. Amsterdam, the Netherlands: Academic Press. 2003;121-150.
14. Steensma DP, Higgs DR, Fisher CA, Gibbons RJ. Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematological phenotype than germline ATRX mutations. Blood. 2004;103:2019-2026.
15. Sassa S, Akagi R, Nishitani C, Harigae H, Furiyama K. Late-onset porphyrias: what are they? Cell Mol Biol (Noisy-le-grand). 2002;48:97-101.
16. Avner DL, Lee RG, Berenson MM. Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver. J Clin Invest. 1981;67:385-394.
17. Do KD, Banner BF, Katz E, Szymanski IO, Bonkovsky HL. Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation. Transplantation. 2002;73:469-472.
18. Dellon ES, Szczepiorkowski ZM, Dzik WH, et al. Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation. 2002;73:911-915.
19. Bench AJ, Nacheva EP, Champion KM, Green AR. Molecular genetics and cytogentics of myeloproliferative disorders. Baillieres Clin Haematol. 1998;11:819-848.
20. Maeck L, Haase D, Schoch C, Hiddemann W, Alves F. Genetic instability in myelodysplastic syndrome: detection of microsatellite instability and loss of heterozygosity in bone marrow samples with karyotype alterations. Br J Haematol. 2000;109:842-846.